en
Scientific article
English

De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects

Published inTransplantation, vol. 83, no. 9, p. 1162-1168
Publication date2007
Abstract

We report long-term outcomes and side effects after transplantation for hepatocellular carcinoma (HCC) using de novo, sirolimus-based immunosuppression (IS).

Keywords
  • Adult
  • Aged
  • Carcinoma, Hepatocellular/surgery
  • Dose-Response Relationship, Drug
  • Female
  • Graft Rejection
  • Humans
  • Immunosuppressive Agents/administration & dosage/adverse effects/therapeutic use
  • Liver Neoplasms/surgery
  • Liver Transplantation/adverse effects
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Patient Selection
  • Pilot Projects
  • Sirolimus/administration & dosage/adverse effects/therapeutic use
  • Survival Analysis
  • Treatment Outcome
Citation (ISO format)
TOSO, Christian et al. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. In: Transplantation, 2007, vol. 83, n° 9, p. 1162–1168. doi: 10.1097/01.tp.0000262607.95372.e0
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0041-1337
542views
0downloads

Technical informations

Creation04/01/2014 12:09:00 PM
First validation04/01/2014 12:09:00 PM
Update time03/14/2023 9:05:15 PM
Status update03/14/2023 9:05:14 PM
Last indexation01/16/2024 9:34:24 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack